Kailera Therapeutics, Inc. (KLRA)
NASDAQ · Manufacturing · Pharmaceutical preparations
KLRA price, last 12 months
Key stats
- Previous close
- $11.79
- Open
- $11.86
- Day range
- $11.28 – $12.06
- 52-week range
- $9.76 – $28.23
- Volume
- 474K
- Avg volume (20 days)
- 817.5K
- Market cap
- $1.7B
Performance
Technicals and fundamentals
About Kailera Therapeutics, Inc.
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.7B